Search results
Results From The WOW.Com Content Network
April 29, 2024 at 2:17 PM. (Reuters) -The U.S. Food and Drug Administration's website showed on Monday one dose of Novo Nordisk's weight-loss drug Wegovy as available after being in short supply ...
Along with lower strength doses of 0.25 mg, 0.5 mg and 1 mg of the drug, the U.S. Food and Drug Administration in its drug shortage list has also listed the 1.7 mg dose with limited availability ...
COPENHAGEN (Reuters) -Denmark faces a supply shortage for two doses of Novo Nordisk's Wegovy weight-loss drug in the coming months due to rising demand, the Danish Medicines Agency said on Monday.
Wegovy sales totalled 9.6 billion Danish crowns ($1.36 billion) between July and September, up 28% from the previous quarter and eight-fold from the same period last year.
Wegovy continues to be in shortage, along with other GLP-1 medicines, as drugmakers struggle to keep up with demand. Novo Nordisk said last month that it’s gradually increasing the supply over ...
Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two separate doses in the coming ...
Novo Nordisk's popular obesity drug Wegovy helped women with a common heart disease lose more weight than men who had the same condition, an analysis of study data published in a medical journal ...
The change comes after, in a late-stage clinical trial of more than 17,000 adults, Novo Nordisk found that Wegovy cut the risk of cardiovascular events — such as heart attack and stroke — by ...